financetom
Business
financetom
/
Business
/
Airbus CEO says SpaceX would not pass anti-trust test in Europe
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Airbus CEO says SpaceX would not pass anti-trust test in Europe
Nov 15, 2024 11:49 AM

*

SpaceX's concentrated model contrasts with Europe's

distributed

approach, Faury says

*

Airbus CEO highlights Europe's need to adapt to SpaceX's

competitiveness

*

Europe's Ariane 6 launcher has yet to stage first

commercial

flight

By Ilona Wissenbach

FRANKFURT, Nov 14 (Reuters) - Elon Musk's hugely

successful rockets-to-satellites SpaceX venture would raise

anti-trust concerns if it had to operate in Europe, the head of

aerospace group Airbus said on Thursday.

SpaceX's insurgent Falcon 9 rocket has slashed launch costs

by introducing reusable rocketry into the commercial industry,

enabling deployment of the company's fast-growing Starlink

constellation, now tallied at nearly 7,000 satellites in orbit.

By contrast, Europe's flagship Ariane 6 launcher, which is

partly built by Airbus, has yet to stage its first

commercial flight after a long-delayed test flight in July. It

plans some 10 flights a year, a fraction of the pace at SpaceX.

"I think what the Americans and what SpaceX have done is

amazing. It's amazing and it's breaking some rules of what we're

doing. It's very concentrated, where with European projects we

are very scattered and distributed," Airbus CEO Guillaume Faury

said.

"So it's launchers, satellites, manufacturing, operating the

constellation. And that's a super-concentrated model that

actually in Europe we are not allowed to think of, for

anti-trust rules," he told an aviation event in Frankfurt.

Backed by Europe's leading space-funding nations such as

France, Airbus and other manufacturers have long complained that

Europe's space industry is hampered by rules requiring work to

be shared between countries involved in funding Ariane.

By contrast, SpaceX is free to decide where to invest and

manufactures 80% of what it needs, Faury said.

"In Europe, we tend to do the ... opposite. We make 20%, we

buy 80%. And by buying 80%, you have a large supply base which

is pleasing everybody. Well, Elon Musk's space is not pleasing

anybody except Elon Musk," Faury said.

SpaceX did not immediately reply to a request for comment.

EUROPE NEEDS TO ADAPT

Despite expressing concerns over the concentration of SpaceX

activities, Faury said Europe must find a way to adapt.

Airbus is in the midst of cutting 2,500 jobs in loss-making

satellite projects. Its rival, defence and technology company

Thales, is also cutting 1,300 jobs.

"(SpaceX) is a super-competitive model. It is re-challenging

what we're doing now in launchers," Faury said.

"If we don't move in launchers and in satellites, if we just

stay with where we are, we're going to be obsolete."

Starlink and its rapid deployment have disrupted the

satellite communications industry and helped shape modern

military strategies in orbit.

NASA plans to use SpaceX to land humans on the moon this decade,

a relationship that could blossom under President-elect Donald

Trump. In May, Reuters reported that SpaceX had been picked to

build a constellation of U.S. spy satellites.

NASA and Pentagon officials have expressed concerns,

privately and sometimes publicly, that the U.S. relies too much

on SpaceX for critical capabilities, and have sought to

stimulate launch and satellite competition.

But anti-trust concerns among SpaceX competitors have so far

gained little traction.

SpaceX advocates and Musk supporters argue that the company

has simply developed innovative, commercially risky technologies

that its rivals have been unwilling to do.

(Writing by Tim Hepher, Joey Roulette)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Law firm Weil opens L.A., San Francisco offices with private equity dealmakers
Law firm Weil opens L.A., San Francisco offices with private equity dealmakers
Jul 9, 2024
July 9 (Reuters) - U.S. law firm Weil, Gotshal & Manges said Tuesday it is opening new offices in Los Angeles and San Francisco with a pair of private equity dealmakers from rival Latham & Watkins. Tana Ryan is joining the firm as managing partner of its new Los Angeles office, while Navneeta Rekhi joins as a partner in Weil's...
Why UniQure Stock Is Soaring
Why UniQure Stock Is Soaring
Jul 9, 2024
UniQure N.V. ( QURE ) shares are trading higher Tuesday after the company announced updated interim data from its ongoing U.S. and European Phase I/II clinical trials of AMT-130 for the treatment of Huntington’s disease. The Details: UniQure ( QURE ) said a statistically significant, dose-dependent, slowing in disease progression measured by cUHDRS was observed through 24 months in patients...
What's Going On With Addiction And Mental Illnesses-Focused Indivior Stock On Tuesday?
What's Going On With Addiction And Mental Illnesses-Focused Indivior Stock On Tuesday?
Jul 9, 2024
Tuesday, Indivior Plc ( INDV ) announced a downward revision of its profit forecast for the year while deciding to cease sales of its schizophrenia drug Perseris. The company also plans to reduce its workforce by about 130 jobs. In a business update, Indivior ( INDV ) outlined its expectations for the second quarter and full-year 2024. Related: Addiction Treatment...
CNS Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule
CNS Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Rule
Jul 9, 2024
11:56 AM EDT, 07/09/2024 (MT Newswires) -- CNS Pharmaceuticals ( CNSP ) said Tuesday it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement for continued listing. The company regained compliance after the closing bid price of its common stock was at $1 per share or greater for the 20 consecutive business days through July 3, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved